CTOs on the Move

Boston MicroFluidics

www.bostonmicrofluidics.com

 
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Boston MicroFluidics raised $17.5M on 08/27/2019

Similar Companies

DoseCue,

DoseCue, LLC is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ameritox Ltd

Ameritox is the nation's leader in pain prescription monitoring. Only Ameritox offers RxGuardian, the most thorough and personalized lab report available.

Foria

Foria is an innovative health & sexual wellness company, rooted in the proven wisdom of plants and powered by compassion. Our all natural Cannabis & Hemp formulas have been changing lives since 2014. As the first brand to create comprehensive product lines for intimacy, relief, and optimal wellbeing for women and people with vulvas, it is our joy and mission to offer effective products for important and under-served life experiences. With an unwavering commitment to clean ingredients, organic & regenerative farming, sex education, and responsible packaging, we maintain the highest standards of purity and transparency — for your health, and the health of our planet.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

HealthLinx Executive Search

HealthLinx Executive Search is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.